[Low doses of aprotinin in reducing blood loss and allogenic transfusions in operation under conditions of extracorporeal circulation with using cell saver].
A blind prospective randomized investigation included 109 patients with ischemic heart disease undergoing operations of coronary shunting under conditions of extracorporeal circulation. It was shown that aprotinin in the dose of 3 ppm KIU in operations of coronary shunting under conditions of reserving autoblood, extracorporeal circulation and using cell saver facilitates reducing postoperative blood loss, but does not lead to less frequent allogenic transfusions.
Naumenko
S E
SE
Naumenko
K S
KS
Pokrovskiĭ
M G
MG
D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use*; D001803:Blood Transfusion / Q000379:methods*; D001026:Coronary Artery Bypass / Q000379:methods*; D004334:Drug Administration Schedule; D005112:Extracorporeal Circulation / Q000379:methods*; D006470:Hemorrhage / Q000517:prevention & control*; D006490:Hemostatics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007430:Intraoperative Care; D011300:Preoperative Care; D011446:Prospective Studies; D014021:Tissue Preservation / Q000379:methods*
D006490:Hemostatics; D007611:Aprotinin